{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:43:14Z","timestamp":1794008594891,"version":"4.8.0"},"reference-count":145,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immunogenic cell death (ICD), a type of regulatory cell death, plays an important role in activating the adaptive immune response. Activation of the tumor-specific immune response is accompanied by the cell surface exposure of calreticulin and heat-shock proteins, the secretion of adenosine triphosphate, and the release of high mobility group box-1. In this review, we summarize and classify the latest types of ICD inducers and their molecular mechanisms, and discuss the effects and potential applications of inducing ICD by chemotherapy drugs, targeted drugs, and oncolytic viruses in clinical research. We also explore the potential role of epigenetic modifiers in the induction of ICD, and clarify the synergistic anti-tumor effects of nano-pulse stimulation, radiosensitizers for radiotherapy, photosensitizers for photodynamic therapy, photothermal therapy, and other physical stimulation, combined with radiotherapy and chemotherapy induced-ICD, in multimodal immunotherapy. In addition, we elucidate the molecular mechanism of ICD in detail, including the calcium imbalance, mitochondrial stress, and the interactions in the tumor microenvironment. Ultimately, this review aims to offer deeper insight into the factors and mechanisms of ICD induction and provide a theoretical basis for the future development of ICD-based immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1571212","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T07:32:42Z","timestamp":1742974362000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["Regulation of immunogenic cell death and potential applications in cancer therapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Kun","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-lan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1755958","article-title":"Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma","volume":"13","author":"Nesic","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X21500233","article-title":"Isoliquiritigenin Suppresses EMT-Induced Metastasis in Triple-Negative Breast Cancer through miR-200c\/C-JUN\/[Formula: see text]-Catenin","volume":"49","author":"Peng","year":"2021","journal-title":"Am J Chin Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170804143706","article-title":"Immune checkpoint inhibitors: basics and challenges","volume":"26","author":"Li","year":"2019","journal-title":"Curr Med Chem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102227","article-title":"Turning tumors from cold to inflamed to improve immunotherapy response","volume":"101","author":"Gerard","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00404","article-title":"Iridium(III)-based PD-L1 agonist regulates p62 and ATF3 for enhanced cancer immunotherapy","volume":"67","author":"Deng","year":"2024","journal-title":"J Med Chem"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94586","article-title":"Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression","volume":"128","author":"Hossain","year":"2018","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19918","article-title":"Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trial","volume":"330","author":"Xu","year":"2023","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.12836","article-title":"Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st randomized clinical trial","volume":"326","author":"Luo","year":"2021","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.02.002","article-title":"Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522","volume":"35","author":"Pusztai","year":"2024","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","article-title":"Calreticulin and cancer","volume":"31","author":"Fucikova","year":"2021","journal-title":"Cell Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1389173","article-title":"Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108130","article-title":"ATP and cancer immunosurveillance","volume":"40","author":"Kepp","year":"2021","journal-title":"EMBO J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"103850","DOI":"10.1016\/j.cellimm.2018.08.011","article-title":"A cycle involving HMGB1, IFN-\u03b3 and dendritic cells plays a putative role in anti-tumor immunity","volume":"343","author":"Gao","year":"2019","journal-title":"Cell Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-021-03605-y","article-title":"Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK\/elF2\u03b1\/ATF4\/CHOP pathway in breast cancer","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0950","article-title":"Human tumor cells killed by anthracyclines induce a tumor-specific immune response","volume":"71","author":"Fucikova","year":"2011","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1984677","article-title":"Trial watch: intratumoral immunotherapy","volume":"10","author":"Humeau","year":"2021","journal-title":"Oncoimmunology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000629","article-title":"Sphingosine kinase inhibition enhances dimerization of calreticulin at the cell surface in mitoxantrone-induced immunogenic cell death","volume":"378","author":"Nduwumwami","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.cdd.4402269","article-title":"Molecular characteristics of immunogenic cancer cell death","volume":"15","author":"Tesniere","year":"2008","journal-title":"Cell Death Differ"},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.112623","article-title":"Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years","volume":"133","author":"D\u2019Angelo","year":"2022","journal-title":"Biomater Adv"},{"key":"B25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jconrel.2022.06.039","article-title":"Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression","volume":"348","author":"Kim","year":"2022","journal-title":"J Control Release"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00544-2","article-title":"Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression","volume":"43","author":"Li","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202401304","article-title":"Dendritic polymer-based nanomedicines remodel the tumor stroma: improve drug penetration and enhance antitumor immune response","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv Mater"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5114\/ceji.2023.132053","article-title":"Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer","volume":"48","author":"Wang","year":"2023","journal-title":"Cent Eur J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.04.011","article-title":"Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation","volume":"357","author":"Gu","year":"2023","journal-title":"J Control Release"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00552-2","article-title":"Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy","volume":"43","author":"Zhu","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.06.016","article-title":"Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer","volume":"95","author":"Park","year":"2019","journal-title":"Oral Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/biom10040643","article-title":"Sequential interferon \u03b2-cisplatin treatment enhances the surface exposure of calreticulin in cancer cells via an interferon regulatory factor 1-dependent manner","volume":"10","author":"Yang","year":"2020","journal-title":"Biomolecules"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1039\/d1cs00933h","article-title":"Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases","volume":"51","author":"Lu","year":"2022","journal-title":"Chem Soc Rev"},{"key":"B35","year":""},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4078","article-title":"The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death","volume":"22","author":"Pozzi","year":"2016","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0313-4","article-title":"T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies","volume":"56","author":"Garrido","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s41467-019-09415-3","article-title":"Crizotinib-induced immunogenic cell death in non-small cell lung cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.3390\/molecules25204764","article-title":"Antibody-drug conjugates for cancer therapy","volume":"25","author":"Hafeez","year":"2020","journal-title":"Molecules (Basel Switzerland)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-2812","article-title":"Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer","volume":"84","author":"Gedik","year":"2024","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.09.033","article-title":"Dual immunostimulatory CD73 antibody-polymeric cytotoxic drug complex for triple negative breast cancer therapy","volume":"189","author":"Xie","year":"2024","journal-title":"Acta biomaterialia"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004704","article-title":"GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies","volume":"10","author":"Pascual-Pasto","year":"2022","journal-title":"J immunotherapy Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1142172","article-title":"Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response","volume":"13","author":"Wu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00074","article-title":"Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity","volume":"4","author":"Guo","year":"2014","journal-title":"Front Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70163-3","article-title":"Immunotherapeutic potential of oncolytic virotherapy","volume":"9","author":"Prestwich","year":"2008","journal-title":"Lancet Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113050","article-title":"Counteracting immunosuppression in the tumor microenvironment by oncolytic newcastle disease virus and cellular immunotherapy","volume":"23","author":"Schirrmacher","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.meegid.2016.01.008","article-title":"Temporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus)","volume":"39","author":"Dimitrov","year":"2016","journal-title":"Infect Genet Evol"},{"key":"B48","article-title":"Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells","volume":"8","author":"Ye","year":"2018","journal-title":"Am J Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/gt.2011.205","article-title":"Measles virus causes immunogenic cell death in human melanoma","volume":"20","author":"Donnelly","year":"2013","journal-title":"Gene Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2174\/1874357901004030123","article-title":"HSV recombinant vectors for gene therapy","volume":"4","author":"Manservigi","year":"2010","journal-title":"Open Virol J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2016.8","article-title":"Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells","volume":"23","author":"Takasu","year":"2016","journal-title":"Cancer Gene Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1517\/14712590802715756","article-title":"Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer","volume":"9","author":"Morse","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.5.3448","article-title":"Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells","volume":"177","author":"Bellone","year":"2006","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03688-13","article-title":"Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer","volume":"88","author":"Angelova","year":"2014","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171093","article-title":"Zika\u00a0virus has oncolytic activity against glioblastoma stem cells","volume":"214","author":"Zhu","year":"2017","journal-title":"J Exp Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.3389\/fmicb.2019.02715","article-title":"Zika virus as oncolytic therapy for brain cancer: myth or reality","volume":"10","author":"Su","year":"2019","journal-title":"Front Microbiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.09.083","article-title":"A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study","volume":"15","author":"Schenk","year":"2020","journal-title":"J Thorac oncology: Off Publ Int Assoc Study Lung Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.1038\/s41467-023-43665-6","article-title":"Zika virus remodelled ER membranes contain proviral factors involved in redox and methylation pathways","volume":"14","author":"Denolly","year":"2023","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat\u00a0Biotechnol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/ncponc0354","article-title":"DNA methylation and gene silencing in cancer","volume":"2","author":"Baylin","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00654","article-title":"Dying to be noticed: epigenetic regulation of immunogenic cell death for cancer immunotherapy","volume":"9","author":"Cruickshank","year":"2018","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00187","article-title":"Combinatorial strategies for the induction of immunogenic cell death","volume":"6","author":"Bezu","year":"2015","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116698","article-title":"The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer","volume":"478","author":"Yin","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3724\/SP.J.1206.2009.00170","article-title":"DNA methylation inhibits ANXA1 gene expression in nasopharyngeal carcinoma cell lines","volume":"36","author":"Tan","year":"2009","journal-title":"Prog Biochem Biophys"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101367","article-title":"Immunomodulatory effect of proteasome inhibitors via the induction of immunogenic cell death in myeloma cells","volume":"16","author":"Matsushita","year":"2023","journal-title":"Pharm (Basel)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0400-z","article-title":"Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy","volume":"41","author":"Gao","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040930","article-title":"Biomarkers of radiotherapy-induced immunogenic cell death","volume":"10","author":"Vaes","year":"2021","journal-title":"Cells"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa268","article-title":"The role of radiotherapy in the age of immunotherapy","volume":"51","author":"Sato","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2020.12.045","article-title":"Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity","volume":"502","author":"Donlon","year":"2021","journal-title":"Cancer Lett"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-018-1287-1","article-title":"Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies","volume":"194","author":"R\u00fcckert","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.968434","article-title":"Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy","volume":"3","author":"Adkins","year":"2015","journal-title":"Oncoimmunology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e28518","DOI":"10.4161\/onci.28518","article-title":"Radiation fosters dosedependent and chemotherapy-induced immunogenic cell death","volume":"3","author":"Golden","year":"2014","journal-title":"Oncoimmunology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1177\/2058738420950584","article-title":"Comparison study of different indoleamine-2,3 dioxygenase inhibitors from the perspective of pharmacodynamic effects","volume":"34","author":"Jiang","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c00397","article-title":"Nanoscale metal-organic frameworks generate reactive oxygen species for cancer therapy","volume":"6","author":"Ni","year":"2020","journal-title":"ACS Cent Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1841393","article-title":"Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death","volume":"9","author":"Gomes-da-Silva","year":"2020","journal-title":"Oncoimmunology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1039\/c8pp00576a","article-title":"Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case report","volume":"18","author":"Schaffer","year":"2019","journal-title":"Photochem Photobiol Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819831989","article-title":"Evaluation on short-term therapeutic effect of 2 porphyrin photosensitizer-mediated photodynamic therapy for esophageal cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216435","article-title":"LW-213 induces immunogenic tumor cell death via ER stress mediated by lysosomal TRPML1","volume":"577","author":"Zhu","year":"2023","journal-title":"Cancer Lett"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0367","article-title":"Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells","volume":"10","author":"Jalili","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1047-x","article-title":"Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release","volume":"60","author":"Korbelik","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b07212","article-title":"Smart nanovesicle-mediated immunogenic cell death through tumor microenvironment modulation for effective photodynamic immunotherapy","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-4305fje","article-title":"Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy","volume":"20","author":"Buytaert","year":"2006","journal-title":"FASEB J"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-007-7030-1","article-title":"Hypericin photoactivation triggers down-regulation of matrix metalloproteinase-9 expression in well-differentiated human nasopharyngeal cancer cells","volume":"64","author":"Du","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1039\/c8nr07627h","article-title":"Recent advances in nanomaterials for enhanced photothermal therapy of tumors","volume":"10","author":"Hu","year":"2018","journal-title":"Nanoscale"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201800678","article-title":"Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma","volume":"14","author":"Sweeney","year":"2018","journal-title":"Small"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004788","article-title":"Recent advances in hyperthermia therapy-based synergistic immunotherapy","volume":"33","author":"Chang","year":"2021","journal-title":"Adv Mater"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.8b05876","article-title":"Photothermal-activatable fe3O4 superparticle nanodrug carriers with PD-L1 immune checkpoint blockade for anti-metastatic cancer immunotherapy","volume":"10","author":"Ge","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"B95","doi-asserted-by":"publisher","first-page":"124314","DOI":"10.1016\/j.cej.2020.124314","article-title":"In situ photothermal activation of necroptosis potentiates black phosphorus-mediated cancer photo-immunotherapy","volume":"394","author":"Zhao","year":"2020","journal-title":"Chem Eng J"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c01453","article-title":"A hepatocellular carcinoma targeting nanostrategy with hypoxia-ameliorating and photothermal abilities that, combined with immunotherapy, inhibits metastasis and recurrence","volume":"14","author":"Zhou","year":"2020","journal-title":"ACS Nano"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.07.006","article-title":"A protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fields","volume":"50","author":"Chen","year":"2014","journal-title":"Eur J Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134364","article-title":"Nanoelectroablation of murine tumors triggers a CD8-dependent inhibition of secondary tumor growth","volume":"10","author":"Nuccitelli","year":"2015","journal-title":"PloS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40425-017-0234-5","article-title":"Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death","volume":"5","author":"Nuccitelli","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B100","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12032-020-01445-y","article-title":"Proteasome inhibitors attenuates mitoxantrone-triggered immunogenic cell death in prostate cancer cells","volume":"37","author":"Wei","year":"2020","journal-title":"Med Oncol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat Rev Drug Discovery"},{"key":"B103","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12985-020-01365-3","article-title":"Novel transcription regulatory sequences and factors of the immune evasion protein ICP47 (US12) of herpes simplex viruses","volume":"17","author":"Cheng","year":"2020","journal-title":"Virol J"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0402","article-title":"Pharmacologic suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers","volume":"10","author":"Song","year":"2020","journal-title":"Cancer Discovery"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101206","article-title":"Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity","volume":"4","author":"Liu","year":"2023","journal-title":"Cell Rep Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2020.12.023","article-title":"Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance","volume":"39","author":"Lin","year":"2021","journal-title":"Cancer Cell"},{"key":"B107","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1038\/s41467-018-05211-7","article-title":"Programmed cell removal by calreticulin in tissue homeostasis and cancer","volume":"9","author":"Feng","year":"2018","journal-title":"Nat Commun"},{"key":"B108","doi-asserted-by":"publisher","first-page":"63ra94","DOI":"10.1126\/scitranslmed.3001375","article-title":"Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47","volume":"2","author":"Chao","year":"2010","journal-title":"Sci Transl Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.06.014","article-title":"Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer","volume":"371","author":"Zhang","year":"2024","journal-title":"J Control Release"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300286","article-title":"In situ vaccination with mitochondria-targeting immunogenic death inducer elicits CD8(+) T cell-dependent antitumor immunity to boost tumor immunotherapy","volume":"10","author":"Wang","year":"2023","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202710","article-title":"Oxidative stress amplifiers as immunogenic cell death nanoinducers disrupting mitochondrial redox homeostasis for cancer immunotherapy","volume":"12","author":"Wan","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"B112","doi-asserted-by":"publisher","first-page":"189154","DOI":"10.1016\/j.bbcan.2024.189154","article-title":"Reactive oxygen species of tumor microenvironment: Harnessing for immunogenic cell death","volume":"1879","author":"Malla","year":"2024","journal-title":"Biochim Biophys Acta Rev cancer"},{"key":"B113","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.bioactmat.2024.06.038","article-title":"ROS-responsive and triple-synergistic mitochondria-targeted polymer micelles for efficient induction of ICD in tumor therapeutics","volume":"36","author":"Hu","year":"2024","journal-title":"Bioactive materials"},{"key":"B114","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biom14020154","article-title":"Curcumin and resveratrol: nutraceuticals with so much potential for pseudoachondroplasia and other ER-stress conditions","volume":"14","author":"Posey","year":"2024","journal-title":"Biomolecules"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.11.005","article-title":"Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c11886","article-title":"ER-targeting cyanine dye as an NIR photoinducer to efficiently trigger photoimmunogenic cancer cell death","volume":"144","author":"Ma","year":"2022","journal-title":"J Am Chem Soc"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/md21120600","article-title":"Ascomylactam C induces an immunogenic cell death signature via mitochondria-associated ER stress in lung cancer and melanoma","volume":"21","author":"Huang","year":"2023","journal-title":"Mar Drugs"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2023.02.011","article-title":"Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2\u03b1 pathway under PTT\/CDT combined therapy","volume":"160","author":"Feng","year":"2023","journal-title":"Acta Biomater"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155504","article-title":"Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer","volume":"128","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116620","article-title":"Marsdenia tenacissima extract induces endoplasmic reticulum stress-associated immunogenic cell death in non-small cell lung cancer cells through targeting AXL","volume":"314","author":"Yuan","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304092","article-title":"Regulation of ion homeostasis for enhanced tumor radio-immunotherapy","volume":"10","author":"Qian","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.51.30749","article-title":"Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum","volume":"270","author":"Schievella","year":"1995","journal-title":"J Biol Chem"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.0c04778","article-title":"Ultrasound-augmented mitochondrial calcium ion overload by calcium nanomodulator to induce immunogenic cell death","volume":"21","author":"Zheng","year":"2021","journal-title":"Nano Lett"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00603","article-title":"Potent zinc(II)-based immunogenic cell death inducer triggered by ROS-mediated ERS and mitochondrial ca2+ Overload","volume":"66","author":"Liao","year":"2023","journal-title":"J Med Chem"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.382","article-title":"Cell death\/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma","volume":"32","author":"Kunkeaw","year":"2013","journal-title":"Oncogene"},{"key":"B126","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1038\/s41598-017-07169-w","article-title":"Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a\/b","volume":"7","author":"\u00c1lvarez-Teijeiro","year":"2017","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20804","article-title":"Epigenetic regulation of miR-196b expression in gastric cancer","volume":"49","author":"Tsai","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-015-2382-6","article-title":"MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation","volume":"404","author":"Yang","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"B129","doi-asserted-by":"publisher","first-page":"19151","DOI":"10.1038\/s41598-023-46669-w","article-title":"Prognostic value and immune landscapes of immunogenic cell death-associated lncRNAs in lung adenocarcinoma","volume":"13","author":"Shu","year":"2023","journal-title":"Sci Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012394","article-title":"Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-\u03baB and inducing immunogenic cell death","volume":"8","author":"Yao","year":"2024","journal-title":"Blood Adv"},{"key":"B131","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12964-024-01731-6","article-title":"Hainanenin-1, an oncolytic peptide, triggers immunogenic cell death via STING activation in triple-negative breast cancer","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1897295","article-title":"The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer","volume":"10","author":"He","year":"2021","journal-title":"Oncoimmunology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2022.01.01","article-title":"Inducing immunogenic cell death in immuno-oncological therapies","volume":"34","author":"Ti","year":"2022","journal-title":"Chin J Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1038\/s41467-023-40270-5","article-title":"Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy","volume":"14","author":"Lee","year":"2023","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.7150\/thno.72509","article-title":"Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy","volume":"12","author":"Mao","year":"2022","journal-title":"Theranostics"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00484","article-title":"Targeting inflammation driven by HMGB1","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2022.04.026","article-title":"ROS-triggered nanoinducer based on dermatan sulfate enhances immunogenic cell death in melanoma","volume":"348","author":"Zhang","year":"2022","journal-title":"J Control Release"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400485","article-title":"Regulation of CTLs\/tregs via highly stable and ultrasound-responsive cerasomal nano-modulators for enhanced colorectal cancer immunotherapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3760766","article-title":"Oxaliplatin induces immunogenic cell death in human and murine laryngeal cancer","volume":"2022","author":"Wang","year":"2022","journal-title":"J Oncol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12100923","article-title":"Mitoxantrone-loaded nanoparticles for magnetically controlled tumor therapy-induction of tumor cell death, release of danger signals and activation of immune cells","volume":"12","author":"Ratschker","year":"2020","journal-title":"Pharmaceutics"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J Exp Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28473","article-title":"Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set","volume":"3","author":"Sukkurwala","year":"2014","journal-title":"Oncoimmunology"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.01.050","article-title":"Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy","volume":"419","author":"Wu","year":"2018","journal-title":"Cancer letters"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1571212\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T07:32:54Z","timestamp":1742974374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1571212\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":145,"alternative-id":["10.3389\/fimmu.2025.1571212"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1571212","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"article-number":"1571212"}}